GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Other Gross PPE

Genflow Biosciences (STU:WQ5) Other Gross PPE : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Other Gross PPE?

Genflow Biosciences's Other Gross PPE for the quarter that ended in Jun. 2024 was €0.00 Mil.

Genflow Biosciences's quarterly Other Gross PPE declined from Jun. 2023 (€0.01 Mil) to Dec. 2023 (€0.00 Mil) but then increased from Dec. 2023 (€0.00 Mil) to Jun. 2024 (€0.00 Mil).

Genflow Biosciences's annual Other Gross PPE increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) and increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.00 Mil).


Genflow Biosciences Other Gross PPE Historical Data

The historical data trend for Genflow Biosciences's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Other Gross PPE Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23
Other Gross PPE
- - -

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Gross PPE Get a 7-Day Free Trial - - 0.01 - -

Genflow Biosciences Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Genflow Biosciences Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines